MedPath

The effects of Fermentable Oligo-, Di-, Monosaccharides, and polyols (FODMAPs) diets on esophageal and gastric function in patients with gastroesophageal reflux disease

Phase 3
Conditions
Gastroesophageal reflux disease
FODMAPs, GERD, Gastric emptying, Gastric accommodation
Registration Number
TCTR20220903002
Lead Sponsor
Faculty of Medicine, Chulalongkorn University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending (Not yet recruiting)
Sex
All
Target Recruitment
20
Inclusion Criteria

1. Diagnosis Gastroesophageal reflux disease by symptom for within 3 months
2. Age 18-70 yr
3. Underwent the EGD within 6 months
4. Have a symptom of GERD by clinical heartburn and/or acid regurgitation
5. Diagnosis GERD with under medication trial for 1-2 months before enrollment

Exclusion Criteria

1. Hx of abdominal surgery except appendectomy and cesarean section
2.current gastric or liver cancer
3.Inflammatory bowel disease)
4.Irritable bowel syndrome)
5.Chronic constipation or abnormal bowel movement
6.Chronic liver disease/Chronic kidney disease
7.Abnormal finding of Esophagogastroduodenoscopy e.g pyloric stenosis
8.Helicobacter pylori infection
9.Esophageal motility disease; Achalasia, EGJ outflow obstruction, Diffuse esophageal spasm, Jackhammer esophagus, Absent peristalsis
10.Concurrent treatment with medication which may interfere the interpretation e.g. proton pump inhibitors, potassium competitive acid blockers, H2 blockers, prokinetics, selective serotonin reuptake inhibitors, antispasmodics, prebiotics, probiotics, antibiotics
11.Uncontrolled psychiatry disease
12.No consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
TLESRs 1 day pH monitoring
Secondary Outcome Measures
NameTimeMethod
Gastric emptying, Gastric accommodation 1 day SPECT CT, Gastric emptying time
© Copyright 2025. All Rights Reserved by MedPath